Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: SPC3649 Multiple Dose Study in Healthy Volunteers [Phase 1]
This Phase 1 multiple-dose study of SPC3649 in healthy volunteers was completed, examining safety and pharmacokinetics for Hepatitis C thera…
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: EXtended Therapy in Hepatitis C Genotype 3 Infected Patients [Phase 3]
Phase 3 trial evaluating extended therapy for hepatitis C genotype 3 infection has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects [Phase 2]
Phase 2 trial evaluating nitazoxanide plus ribavirin and peginterferon for treatment-naive HIV coinfected subjects with Hepatitis C Genotype…
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED) [Phase 1]
Phase 1 study evaluating magnetic resonance elastography to assess liver fibrosis completed; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)
This completed clinical trial evaluated whether insulin resistance affects the safety and efficacy of pegylated interferon plus ribavirin th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-15Clinical Trial Update: Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation
Update on a clinical trial evaluating biomarkers for recurrent hepatitis C infection after liver transplantation.
-
CLINICAL_TRIALS trial_result · 2011-09-15Clinical Trial Update: A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated whether milk thistle treatment is more effective than no treatment in patients co-infected wi…
-
CLINICAL_TRIALS trial_result · 2011-09-14Clinical Trial Update: Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid [Phase 3]
Phase 3 trial comparing Tacrolimus + Mycophenolate mofetil versus Tacrolimus + corticosteroids to assess hepatitis C recurrence after living…
-
CLINICAL_TRIALS trial_result · 2011-08-31Clinical Trial Update: Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1)
This clinical trial update reports on the efficacy, safety, and adherence of hepatitis C patients treated with Infergen (interferon alfacon-…
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment [Phase 3]
Phase 3 clinical trial update reporting the safety and effectiveness of telaprevir in chronic genotype 1 hepatitis C patients who failed pri…
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3) [Phase 3]
A Phase 3 efficacy trial evaluating new treatment schedules in treatment-naive patients with genotype 3 hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients [NA]
This clinical trial update concerns a study aimed at preventing depression in patients co-infected with HIV and Hepatitis C who have substan…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C [Phase 4]
Phase 4 clinical trial evaluating pegylated interferon plus ribavirin in active and past intravenous drug users with hepatitis C has complet…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy [Phase 2]
A Phase 2 rollover trial update for Hepatitis C patients who were in the control arms of VX06-950-106, VX05-950-104 and VX05-950-104EU studi…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV) [Phase 3]
A Phase 3 study of telaprevir in combination with Pegasys and Copegus in treatment-naive genotype 1 hepatitis C patients completed, with res…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3) [Phase 2]
This clinical trial update reports the completion of the Phase 2 PROVE3 study evaluating telaprevir in combination with peginterferon alfa-2…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C [Phase 2]
A Phase 2 study evaluating VX-950 (telaprevir) in combination with pegylated interferon alfa-2a, with or without ribavirin (Copegus) for chr…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C [Phase 2]
Phase 2 study evaluating VX-950 (telaprevir) in combination with Pegasys and Copegus for chronic hepatitis C has completed and posted result…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response [Phase 3]
Phase 3 trial evaluating 24- or 48-week telaprevir-based regimens in treatment-naïve genotype 1 Hepatitis C patients achieving extended rapi…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users [Phase 4]
Phase 4 clinical trial comparing raltegravir to a protease inhibitor in treatment-naïve HIV/Hepatitis C drug users. The update provides no r…
-
CLINICAL_TRIALS trial_result · 2011-07-07Clinical Trial Update: MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED) [Phase 1]
Phase 1 trial of MRKAd5 HIV-1 Gag Vaccine (V520) in adults with chronic hepatitis C has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: 14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response [Phase 3]
Phase 3 trial comparing 14-week versus 24-week hepatitis C treatment in genotype 2/3 patients with rapid virological response has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects [Phase 2]
A Phase 2 multiple ascending dose study of BMS-650032 in chronic hepatitis C patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3 [Phase 4]
A Phase 4 trial evaluating low-dose peginterferon in combination with ribavirin to treat chronic hepatitis C in patients infected with HCV g…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED) [Phase 3]
Phase 3 study evaluating boceprevir in adults with chronic hepatitis C genotype 1 who failed prior peginterferon/ribavirin therapy has been …